Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Angela R. Jones-Leone"'
Autor:
Christel Wilkinson, Robert B. Henderson, Angela R. Jones-Leone, Shaun M. Flint, Mark Lennon, Roger A. Levy, Beulah Ji, Damon L. Bass, David Roth
Publikováno v:
Arthritis Research & Therapy, Vol 22, Iss 1, Pp 1-11 (2020)
Abstract Background Elevated B lymphocyte stimulator (BLyS) levels in patients with systemic lupus erythematosus (SLE) correlate positively with disease activity; BLyS expression is directly linked to interferon (IFN) pathway activation. This post ho
Externí odkaz:
https://doaj.org/article/0924274602404ad3a219d4663a5e0c26
Autor:
Hisashi Noma, Holly Quasny, Roger A Levy, Kerry Gairy, Noriaki Kurita, Nobuyuki Yajima, Kenei Sada, Taizo Matsuki, Angela R Jones-Leone
Publikováno v:
Lupus Science and Medicine, Vol 9, Iss 1 (2022)
Introduction Lupus nephritis (LN) is more prevalent in patients with SLE of Asian ethnicity than in Caucasian patients. Belimumab became available in Japan in 2017 to treat patients with SLE, including those with LN. In the BLISS-LN trial (NCT0163933
Externí odkaz:
https://doaj.org/article/06d54f05c93c4512bac6c2aad2f323f6
Autor:
Kenei Sada, Noriaki Kurita, Hisashi Noma, Taizo Matsuki, Holly Quasny, Roger A Levy, Angela R Jones-Leone, Kerry Gairy, Nobuyuki Yajima
Publikováno v:
Lupus Science & Medicine. 9:e000746
IntroductionLupus nephritis (LN) is more prevalent in patients with SLE of Asian ethnicity than in Caucasian patients. Belimumab became available in Japan in 2017 to treat patients with SLE, including those with LN. In the BLISS-LN trial (NCT01639339
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8c387c8fd63abbc127484922f62cb057
https://doi.org/10.1136/lupus-2022-000746
https://doi.org/10.1136/lupus-2022-000746